Quotes 5-day view Delayed Nasdaq
01/27/2023
01/30/2023
01/31/2023
02/01/2023
02/02/2023
Date
122.5(c)
120.8(c)
124.08(c)
123.5(c)
120.98
Last
153 978
359 051
145 655
157 206
33 971
Volume
+0.80%
-1.39%
+2.72%
-0.47%
-2.04%
Change
Estimated financial data (e) EUR USD
Sales 2022
45,8 M
50,0 M
50,0 M
Net income 2022
-530 M
-578 M
-578 M
Net cash position 2022
455 M
497 M
497 M
P/E ratio 2022
-11,8x
Yield 2022
-
Sales 2023
148 M
162 M
162 M
Net income 2023
-546 M
-596 M
-596 M
Net Debt 2023
83,1 M
90,7 M
90,7 M
P/E ratio 2023
-11,7x
Yield 2023
-
Capitalization
6 334 M
6 916 M
6 916 M
EV / Sales 2022
128x
EV / Sales 2023
43,4x
Nbr of Employees
639
Free-Float
10,3%
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology,...
Ratings of Ascendis Pharma A/S
All news about ASCENDIS PHARMA A/S
News in other languages on ASCENDIS PHARMA A/S
Analyst Recommendations on ASCENDIS PHARMA A/S
ETFs positioned on ASCENDIS PHARMA A/S ETFs and Trackers with Trackinsight
Chart ASCENDIS PHARMA A/S
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends ASCENDIS PHARMA A/S
Short Term Mid-Term Long Term Trends Neutral Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
14
Last Close Price
113,11 €
Average target price
146,94 €
Spread / Average Target
29,9%
Please enable JavaScript in your browser's settings to use dynamic charts.